Shuai Liu1,2,3,4,5, Dong Zhao1,2,3,4,5, Miao Wang1,2,3,4,5, Yue Qi1,2,3,4,5, Jiayi Sun1,2,3,4,5, Jun Liu1,2,3,4,5, Yan Li1,2,3,4,5, Jing Liu6,7,8,9,10. 1. Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing, China. 2. Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China. 3. National Clinical Research Center of Cardiovascular Diseases, Beijing, China. 4. The Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing, China. 5. Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing, China. 6. Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing, China. jingliu@ccmu.edu.cn. 7. Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China. jingliu@ccmu.edu.cn. 8. National Clinical Research Center of Cardiovascular Diseases, Beijing, China. jingliu@ccmu.edu.cn. 9. The Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing, China. jingliu@ccmu.edu.cn. 10. Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing, China. jingliu@ccmu.edu.cn.
Abstract
BACKGROUND: Dyskalemia involves critical electrolyte abnormalities and increases mortality risk in patients with acute clinical conditions. However, the association between dyskalemia and adverse outcomes in the general population is less well established. OBJECTIVE: To investigate the association of serum potassium levels with mortality and cardiovascular events in the general population and to explore the characteristics of individuals at high risk. DESIGN: A prospective cohort study. PARTICIPANTS: A total of 5220 participants aged 50-79 years in the Chinese Multi-provincial Cohort Study. MAIN MEASURES: Serum potassium levels were measured by the ion-selective electrode method. The outcomes were incident cardiovascular disease (CVD), CVD death, non-CVD death, and total death. KEY RESULTS: Of the 5220 participants, 48.2% were men, and the mean age was 62.3 (SD 7.6) years. Hyperkalemia was found in 8.7% of the participants and was significantly associated with total death (hazard ratio [HR], 1.62; 95% confidence interval [CI], 1.18-2.23) and CVD death (HR, 2.12; 95% CI, 1.25-3.61) after adjustment. Furthermore, the HRs (95% CIs) of hyperkalemia combined with 2 and ≥ 3 risk factors were 2.37 (1.50-3.74) and 4.06 (2.37-6.95) for total death and 3.26 (1.56-6.80) and 8.42 (4.06-17.50) for CVD death, respectively. The 10-year cumulative incidence of total death was 17.4% for participants with 2 or more risk factors. CONCLUSION: Hyperkalemia is associated with an increased risk of all-cause and CVD death, and this risk is more pronounced in patients with multiple risk factors. Our findings suggest that early identification and management of hyperkalemia in the general population are warranted.
BACKGROUND: Dyskalemia involves critical electrolyte abnormalities and increases mortality risk in patients with acute clinical conditions. However, the association between dyskalemia and adverse outcomes in the general population is less well established. OBJECTIVE: To investigate the association of serum potassium levels with mortality and cardiovascular events in the general population and to explore the characteristics of individuals at high risk. DESIGN: A prospective cohort study. PARTICIPANTS: A total of 5220 participants aged 50-79 years in the Chinese Multi-provincial Cohort Study. MAIN MEASURES: Serum potassium levels were measured by the ion-selective electrode method. The outcomes were incident cardiovascular disease (CVD), CVD death, non-CVD death, and total death. KEY RESULTS: Of the 5220 participants, 48.2% were men, and the mean age was 62.3 (SD 7.6) years. Hyperkalemia was found in 8.7% of the participants and was significantly associated with total death (hazard ratio [HR], 1.62; 95% confidence interval [CI], 1.18-2.23) and CVD death (HR, 2.12; 95% CI, 1.25-3.61) after adjustment. Furthermore, the HRs (95% CIs) of hyperkalemia combined with 2 and ≥ 3 risk factors were 2.37 (1.50-3.74) and 4.06 (2.37-6.95) for total death and 3.26 (1.56-6.80) and 8.42 (4.06-17.50) for CVD death, respectively. The 10-year cumulative incidence of total death was 17.4% for participants with 2 or more risk factors. CONCLUSION: Hyperkalemia is associated with an increased risk of all-cause and CVD death, and this risk is more pronounced in patients with multiple risk factors. Our findings suggest that early identification and management of hyperkalemia in the general population are warranted.
Authors: Jan M Hughes-Austin; Dena E Rifkin; Tomasz Beben; Ronit Katz; Mark J Sarnak; Rajat Deo; Andrew N Hoofnagle; Shunichi Homma; David S Siscovick; Nona Sotoodehnia; Bruce M Psaty; Ian H de Boer; Bryan Kestenbaum; Michael G Shlipak; Joachim H Ix Journal: Clin J Am Soc Nephrol Date: 2017-01-31 Impact factor: 8.237
Authors: Abhinav Goyal; John A Spertus; Kensey Gosch; Lakshmi Venkitachalam; Philip G Jones; Greet Van den Berghe; Mikhail Kosiborod Journal: JAMA Date: 2012-01-11 Impact factor: 56.272
Authors: Allan J Collins; Bertram Pitt; Nancy Reaven; Susan Funk; Karen McGaughey; Daniel Wilson; David A Bushinsky Journal: Am J Nephrol Date: 2017-09-02 Impact factor: 3.754
Authors: Jing Liu; Yuling Hong; Ralph B D'Agostino; Zhaosu Wu; Wei Wang; Jiayi Sun; Peter W F Wilson; William B Kannel; Dong Zhao Journal: JAMA Date: 2004-06-02 Impact factor: 56.272